LAURUSLABS.NS
LAURUSLABS.NS
INE947Q01028
LAURUS LABS LIMITED
Loading chart...

Company Profile

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Related stocks

ZYDUSLIFE.NS
ZYDUSLIFE.NS • India
ZYDUS LIFESCIENCES LTD
1,117.5 INR
11.52B USD 1Y +12.8%
RDY
RDY • India
Dr. Reddy's Laboratories Ltd
12.48 USD
10.4B USD 1Y -12.8%
DRREDDY.NS
DRREDDY.NS • India
DR. REDDY S LABORATORIES
1,197 INR
10.3B USD 1Y -3.9%
MANKIND.NS
MANKIND.NS • India
MANKIND PHARMA LIMITED
2,368.5 INR
10.11B USD 1Y -3.1%
CIPLA.NS
CIPLA.NS • India
CIPLA LTD
1,301 INR
10.86B USD 1Y -14%
LUPIN.NS
LUPIN.NS • India
LUPIN LIMITED
1,956.5 INR
9.24B USD 1Y -0.1%
AUROPHARMA.NS
AUROPHARMA.NS • India
AUROBINDO PHARMA LTD
1,693 INR
10.07B USD 1Y +51.2%
ALKEM.NS
ALKEM.NS • India
ALKEM LABORATORIES LTD.
5,279 INR
6.52B USD 1Y -4.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.0% p.a.
Max Drawdown (5Y)
-55.5%
Sharpe Ratio (5Y)
0.71
Beta Factor
0.34
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 100.7 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -59.1% in the extended horizon.
ende